Inventor · disambiguated record
David Hagerty
Also filed as: HAGERTY DAVID
9 granted patents·3 pending applications·139 citations·filing 2001–2025
90Inventor score
Files withBRISTOL MYERS SQUIBB CO7COHEN ROBERT3THE GOVERNMENT OF THE US SECRETARY OF HOMELAND SECURITY1
Top patents by PatentIndex Score
12 records- 0192US8497247B2Methods for treating type I diabetes mellitus by administering a soluble CTLA4 moleculeCOHEN ROBERT·Filed 2012·Granted Jul 30, 2013·15 cites·8 claims
- 0292US7455835B2Methods for treating immune system diseases using a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 25, 2008·57 cites·31 claims
- 0391US7482327B2Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant moleculesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 27, 2009·23 cites·25 claims
- 0489US8722632B2Methods for treating Sjogrens syndrome by administering a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 13, 2014·9 cites·8 claims
- 0589US8227420B2Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAIDCOHEN ROBERT·Filed 2010·Granted Jul 24, 2012·10 cites·34 claims
- 0689US8148332B2Method for treating a rheumatic disease using a soluble TLA4 moleculeCOHEN ROBERT·Filed 2011·Granted Apr 3, 2012·9 cites·8 claims
- 0788US9296808B2Methods for treating scleroderma by administering a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 29, 2016·7 cites·1 claims
- 0888US8703718B2Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 22, 2014·7 cites·8 claims
- 0982US10052360B2Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 21, 2018·2 cites·16 claims
- 1058US2025356025A1Risk Assessment Tool for Target DocumentsTHE GOVERNMENT OF THE US SECRETARY OF HOMELAND SECURITY·Filed 2025·Application pending·0 cites
- 1157US2010041602A1Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant moleculesBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1255US2004022787A1Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAIDFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Hagerty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →